Clinical trial
Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of…
NCT00132119 · Somaxon Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00132119 |
|---|---|
| Title | Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Nalmefene HCl in the Treatment of Pathological Gambling |
| Lead sponsor | Somaxon Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Pathological Gambling |
| Intervention type | Drug, Other |
| Interventions | nalmefene HCl, Placebo |
| Enrollment | 233 |
| Start date | Aug 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Aug 19, 2005 |
| Last update posted | May 19, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: